|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 404.9 INR | -0.50% |
|
-0.93% | +57.82% |
| Feb. 10 | Gujarat Themis Biosyn Limited Approves an Interim Dividend for the Year 2023-24 | CI |
| Feb. 10 | Gujarat Themis Biosyn Limited Approves Interim Dividend for the Financial Year 2023-24 | CI |
Gujarat Themis Biosyn Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 281.73 million compared to INR 287.63 million a year ago. Revenue was INR 295.71 million compared to INR 302.72 million a year ago.
Net income was INR 116.92 million compared to INR 97.89 million a year ago. Basic earnings per share from continuing operations was INR 1.61 compared to INR 1.348 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +57.82% | 353M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B | |
| -2.27% | 4.81B |
GUJARAT THEMIS BIOSYN LIMITED 
